Skip to main content
German Center for Infection Research
  • Research
    • Back
    • Bridging Topics
    • Research Areas
    • Infrastructures
    • Working Groups
    • Projects
    • African Partner Institutions
    • Clinical Trials
    • Publications
  • Translation
    • Back
    • Developing Medication
    • Successful Translation
    • Collaborations
    • German Centers for Health Research
  • DZIF Academy
  • Newsroom
    • Back
    • News
    • Media Centre
    • Press Office
    • Events
    • Jobs
  • About us
    • Back
    • Portrait
    • DZIF Structure and Bodies
    • Partner Sites
    • Executive Board
    • DZIF Patient Advisory Board
    • Staff
    • Main Office
    • Donations
  • De
  • |
  • En

Search

Breadcrumb

  1. Home
  2. Search
Impfstoffforschung

Please use this image only in connection with this press release.

© fernando zhiminaicela auf Pixabay

© fernando zhiminaicela auf Pixabay
Nov 24 2021

A study on booster vaccination with the MVA-SARS-2-ST vector vaccine is starting at the UKE

Approximately two-thirds of the population in Germany have been fully vaccinated against the corona virus to date. But the immune protection from the vaccine diminishes over time. A booster

Unterzeichner des Joint Statements
Nov 17 2021

20 research, medical and pharmaceutical organizations call on G7 to step up action against antibiotic resistance

Ahead of the “World Antimicrobial Awareness Week” (November 18-24) 20 national and international organizations from academia, healthcare, global health and the pharmaceutical industry appealed today

Aug 2021
Vaccines (Basel)

Stepwise Conformational Stabilization of a HIV-1 Clade C Consensus Envelope Trimer Immunogen Impacts the Profile of Vaccine-Induced Antibody Responses

Autoren
Hauser A et al.
Jul 2021
Euro Surveill

Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021

Autoren
Kroidl I et al.
Aug 2021
Wien Klin Wochenschr

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial

Autoren
Kremsner PG et al.
Aug 2021
EBioMedicine

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis

Autoren
Strengert M et al.
Aug 2021
Drugs R&D

Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2

Autoren
Sprute R et al.
NA-PATH-Logo
Oct 5 2021

Be better prepared for pandemics

The German Center for Infection Research (DZIF) and the Helmholtz Centre for Infection Research (HZI) have developed a concept to form a National Alliance for Pandemic Therapeutics (NA-PATH). They

Jun 2021
Proc Natl Acad Sci U S A

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination

Autoren
Tscherne A et al.
Jun 2021
PLoS Negl Trop Dis

Exploratory analysis of the effect of helminth infection on the immunogenicity and efficacy of the asexual blood-stage malaria vaccine candidate GMZ2

Autoren
Nouatin O et al.

Pagination

Previous page ‹‹
Seite 21 Seite 22 Seite 23 Seite 24 Current page 25 Seite 26 Seite 27 Seite 28 Seite 29
Next page ››

Sitemap

  • Research
  • Translation
  • DZIF Academy
  • Newsroom
  • About us

At one click

  • Jobs
  • Media Centre
  • Press releases
  • Press contact
  • Glossary
  • Donations

Newsletter Subscription

Contact

Main Office of the DZIF e. V.
Inhoffenstraße 7
38124 Braunschweig
​

E-Mail Send mail

Fußbereichsmenü

  • DZIF Portal (internal)
  • Whistleblower system
  • Imprint
  • Privacy policy
  • Log in
  • Manage cookie consent
German Centers for Health Research
Supported by the Federal Ministry of Research, Technology and Space and the participating federal states